DMD, dystrophin, 1756

N. diseases: 484; N. variants: 345
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033141
Disease: Cardiomyopathies, Primary
Cardiomyopathies, Primary
0.300 Therapeutic group CTD_human Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy. 20675662 2010
CUI: C0033141
Disease: Cardiomyopathies, Primary
Cardiomyopathies, Primary
0.300 Biomarker group CTD_human Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. 18340010 2008
CUI: C0033141
Disease: Cardiomyopathies, Primary
Cardiomyopathies, Primary
0.300 Biomarker group CTD_human Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy. 20675662 2010
CUI: C0033141
Disease: Cardiomyopathies, Primary
Cardiomyopathies, Primary
0.300 Therapeutic group CTD_human Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. 17440445 2007
CUI: C0033141
Disease: Cardiomyopathies, Primary
Cardiomyopathies, Primary
0.300 Biomarker group CTD_human Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. 17440445 2007
CUI: C0033141
Disease: Cardiomyopathies, Primary
Cardiomyopathies, Primary
0.300 Therapeutic group CTD_human Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. 18340010 2008